RISK MANAGEMENT STRATEGIES FOR REDUCING ORAL ADVERSE DRUG EVENTS

被引:5
|
作者
Spolarich, Ann Eshenaur [1 ,2 ]
机构
[1] USC, Div Dent Publ Hlth & Pediat Dent, Ostrow Sch Dent, Los Angeles, CA 90089 USA
[2] USC, Natl Ctr Dent Hyg Res & Practice, Ostrow Sch Dent, Los Angeles, CA 90089 USA
关键词
Oral adverse drug events; xerostomia; drug-induced ulceration; mucositis; lichenoid drug reaction; CLINICAL-PRACTICE GUIDELINES; SALIVARY-GLANDS; ANTIMICROBIALS; AGENTS;
D O I
10.1016/j.jebdp.2014.04.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral adverse drug effects negatively impact oral health, comfort and function. Background Patients treated in the oral health care environment take multiple medications, many of which cause oral complications. Dental professionals are challenged with making recommendations to prevent or minimize drug-induced oral disease risks, while reducing symptoms to improve oral health quality of life. Methods This paper presents a critical analysis of current evidence regarding common oral adverse drug events, and reviews existing clinical practice guidelines based upon findings from published systematic reviews. Results There is a lack of sufficient, high quality evidence to support most recommendations for interventions to relieve signs and symptoms of drug-induced oral adverse events. Existing recommendations are largely based on data obtained from observational studies and case reports, and from randomized controlled clinical trials with significant design flaws and potential reporting bias. Outcome measures, especially those related to symptom relief and long-range benefits, are either insufficient or lacking. Conclusions Oral adverse drug effects are a common problem, and additional data is needed to support best practices for product recommendations to improve oral health in medicated patients.
引用
收藏
页码:87 / +
页数:9
相关论文
共 50 条
  • [41] Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies
    Gabison, Eric E.
    Rousseau, Antoine
    Labetoulle, Marc
    Gazzah, Anas
    Besse, Benjamin
    PROGRESS IN RETINAL AND EYE RESEARCH, 2024, 103
  • [42] Risk Factors for Hospital Admissions Associated with Adverse Drug Events
    Kongkaew, Chuenjid
    Hann, Mark
    Mandal, Jaydeep
    Williams, Steven D.
    Metcalfe, David
    Noyce, Peter R.
    Ashcroft, Darren M.
    PHARMACOTHERAPY, 2013, 33 (08): : 827 - 837
  • [43] ADVERSE CHILDHOOD EVENTS AS RISK FACTORS FOR ALCOHOL AND DRUG DEPENDENCE
    Chan, G.
    Douglas, K.
    Gelernter, J.
    Arias, A. J.
    Anton, R. F.
    Weiss, R. D.
    Bardy, K.
    Poling, J.
    Farrer, L.
    Kranzler, H. R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 69A - 69A
  • [44] Risk factors for the development of adverse drug events in hospitalized patients
    van den Bemt, PMLA
    Egberts, ACG
    Lenderink, AW
    Verzijl, JM
    Simons, KA
    van der Pol, WSCJM
    Leufkens, HGM
    PHARMACY WORLD & SCIENCE, 2000, 22 (02): : 62 - 66
  • [45] Categorization and association analysis of risk factors for adverse drug events
    Zhou, Lina
    Rupa, Anamika Paul
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 389 - 404
  • [46] Patient risk factors for adverse drug events in hospitalized patients
    Bates, DW
    Miller, EB
    Cullen, DJ
    Burdick, L
    Williams, L
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Vander Vliet, M
    Leape, LL
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2553 - 2560
  • [47] Risk factors in preventable adverse drug events in pediatric outpatients
    Zandieh, Stephanie O.
    Goldmann, Donald A.
    Keohane, Carol A.
    Yoon, Catherine
    Batfs, David W.
    Kaushal, Rainu
    JOURNAL OF PEDIATRICS, 2008, 152 (02): : 225 - 231
  • [48] Risk factors for the development of adverse drug events in hospitalized patients
    P.M.L.A. van den Bemt
    A.C.G. Egberts
    A.W. Lenderink
    J.M. Verzijl
    K.A. Simons
    W.S.C.J.M. van der Pol
    H.G.M. Leufkens
    Pharmacy World and Science, 2000, 22 : 62 - 66
  • [49] Categorization and association analysis of risk factors for adverse drug events
    Lina Zhou
    Anamika Paul Rupa
    European Journal of Clinical Pharmacology, 2018, 74 : 389 - 404
  • [50] Identification of risk factors for adverse drug events in a general hospital
    Pisetta, Leticia Mara
    Tonin, Fernanda Zanardo
    Akiyoshi, Fernando Kenji
    Santos, Fabio Andre
    Fernandes, Daniel
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2024, 36 (03)